Professor Bo Angelin MD, PhD

Senior Professor of Clinical Metabolic Research at Karolinska Institutet; Head of the Department of Endocrinology, Metabolism & Diabetes at Karolinska University Hospital; Director of the KI/AZ Integrated Cardiometabolic Center (ICMC), Sweden

Bo Angelin, MD, PhD, is senior professor of clinical metabolic research at Karolinska Institutet, and has served as head of the Department of Endocrinology, Metabolism & Diabetes at Karolinska University Hospital and director of the KI/AZ Integrated Cardiometabolic Center (ICMC). He is studying mechanisms of regulation of lipid and cholesterol metabolism with special emphasis on humans, and how this knowledge can be used for development of new forms of diagnostics and treatments. A major interest has continued to be the exploration of monogenic dyslipidemias, particularly in relation to disturbances of bile acid enterohepatic circulation. He has served as president of the European Atherosclerosis Society, been a member and chairperson of the Nobel Assembly and the Nobel Committee of Karolinska Institutet, and is a member of the Swedish Royal Academy of Sciences. His collaborations with industry include serving as a board member (non-executive director) of AstraZeneca PLC.